Chavas Leonard M G, Tringali Cristina, Fusi Paola, Venerando Bruno, Tettamanti Guido, Kato Ryuichi, Monti Eugenio, Wakatsuki Soichi
Structural Biology Research Center, Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan.
J Biol Chem. 2005 Jan 7;280(1):469-75. doi: 10.1074/jbc.M411506200. Epub 2004 Oct 22.
Gangliosides play key roles in cell differentiation, cell-cell interactions, and transmembrane signaling. Sialidases hydrolyze sialic acids to produce asialo compounds, which is the first step of degradation processes of glycoproteins and gangliosides. Sialidase involvement has been implicated in some lysosomal storage disorders such as sialidosis and galactosialidosis. Neu2 is a recently identified human cytosolic sialidase. Here we report the first high resolution x-ray structures of mammalian sialidase, human Neu2, in its apo form and in complex with an inhibitor, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA). The structure shows the canonical six-blade beta-propeller observed in viral and bacterial sialidases with its active site in a shallow crevice. In the complex structure, the inhibitor lies in the catalytic crevice surrounded by ten amino acids. In particular, the arginine triad, conserved among sialidases, aids in the proper positioning of the carboxylate group of DANA within the active site region. The tyrosine residue, Tyr(334), conserved among mammalian and bacterial sialidases as well as in viral neuraminidases, facilitates the enzymatic reaction by stabilizing a putative carbonium ion in the transition state. The loops containing Glu(111) and the catalytic aspartate Asp(46) are disordered in the apo form but upon binding of DANA become ordered to adopt two short alpha-helices to cover the inhibitor, illustrating the dynamic nature of substrate recognition. The N-acetyl and glycerol moieties of DANA are recognized by Neu2 residues not shared by bacterial sialidases and viral neuraminidases, which can be regarded as a key structural difference for potential drug design against bacteria, influenza, and other viruses.
神经节苷脂在细胞分化、细胞间相互作用和跨膜信号传导中发挥关键作用。唾液酸酶水解唾液酸以产生去唾液酸化合物,这是糖蛋白和神经节苷脂降解过程的第一步。唾液酸酶的参与与某些溶酶体贮积症有关,如唾液酸沉积症和半乳糖唾液酸沉积症。Neu2是最近发现的一种人类胞质唾液酸酶。在此,我们报告了哺乳动物唾液酸酶人类Neu2的首个高分辨率x射线结构,其为无配体形式以及与抑制剂2-脱氧-2,3-脱氢-N-乙酰神经氨酸(DANA)形成的复合物形式。该结构显示出在病毒和细菌唾液酸酶中观察到的典型六叶β-螺旋桨结构,其活性位点位于一个浅裂缝中。在复合物结构中,抑制剂位于由十个氨基酸包围的催化裂缝中。特别地,在唾液酸酶中保守的精氨酸三联体有助于将DANA的羧基正确定位在活性位点区域内。酪氨酸残基Tyr(334)在哺乳动物和细菌唾液酸酶以及病毒神经氨酸酶中均保守,通过稳定过渡态中的假定碳正离子来促进酶促反应。含有Glu(111)和催化性天冬氨酸Asp(46)的环在无配体形式下无序,但在结合DANA后变得有序,形成两个短α-螺旋以覆盖抑制剂,说明了底物识别的动态性质。DANA的N-乙酰基和甘油部分被Neu2中细菌唾液酸酶和病毒神经氨酸酶所没有的残基识别,这可被视为针对细菌、流感和其他病毒进行潜在药物设计的关键结构差异。